<DOC>
	<DOCNO>NCT02884557</DOCNO>
	<brief_summary>Inflammatory bowel disease ( IBD ) include Crohn 's disease ( CD ) ulcerative colitis ( UC ) . These diseases public health problem concern many patient ( 1 case 1000 ) . IBDs characterize dysregulated immune response luminal antigen cause chronic inflammation gut genetically predispose individual . Their exact cause unknown currently cure . The primary sclerosing cholangitis ( PSC ) liver inflammatory disease unknown origin know strongly associate IBD . An important clinical observation highlight mild symptom IBD associate PSC . Conversely , treat PSC liver transplant immunosuppressive drug associate progression intestinal inflammation . Based , clinical finding suggest protective effect regulator liver inflammation intestinal inflammation , result obtain group mouse model identify natural killer T cell ( NKT ) essential control experimental colitis , project aim determine , use PCR , expression NKT cell marker increase colon patient PSC+IBD compare patient IBD alone PSC alone .</brief_summary>
	<brief_title>NKT Role Regulation Inflammatory Bowel Disease</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Cholangitis</mesh_term>
	<mesh_term>Cholangitis , Sclerosing</mesh_term>
	<criteria>Patients PSC alone , IBD alone PSC + IBD Obtention oral write consent Patients affiliate social security system Minor patient Suspicion malignant lesion colon Inability information person unable consent , benefit legal protection regimen Person deprive liberty</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>